glp-1 analogues names Holding Agonists Prior to Elective Procedures GLP-1s and Hormone Therapy: A

[DOI] [PMC free article] [PubMed] [Google Scholar] 487.Harndahl L., Wierup N., Enerback S., Mulder H., Manganiello V.C., Sundler F

Trials have demonstrated reductions in major adverse cardiovascular events along with significant weight reduction, particularly with agents such as semaglutide and dulaglutide

For nauseathe most common GLP-1 side effectnote whether it occurs primarily after injections, with meals, or throughout the day

Those who complained of gastrointestinal adverse effects were also more likely to discontinue use as well as those who lost more weight

Prescribers must ensure that thyroid function is optimised and stable before initiating GLP-1 receptor agonist therapy

Our content is based on peer-reviewed research, medically reviewed data, and trusted clinical references to ensure reliability and relevance